NOVOCURE LTD's ticker is and the CUSIP is G6674U908. A total of 4 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $720 | -88.3% | 44,600 | -69.9% | 0.00% | -80.0% |
| Q2 2023 | $6,146 | -12.5% | 148,100 | +26.8% | 0.01% | -16.7% |
| Q1 2023 | $7,024 | +106.8% | 116,800 | +152.3% | 0.01% | +50.0% |
| Q4 2022 | $3,396 | -99.9% | 46,300 | +38.6% | 0.00% | +33.3% |
| Q3 2022 | $2,537,000 | +38.9% | 33,400 | +27.0% | 0.00% | +50.0% |
| Q2 2022 | $1,827,000 | -53.7% | 26,300 | -44.7% | 0.00% | -50.0% |
| Q1 2022 | $3,943,000 | +43.9% | 47,600 | +30.4% | 0.00% | +33.3% |
| Q4 2021 | $2,740,000 | -15.5% | 36,500 | +113.5% | 0.00% | 0.0% |
| Q3 2021 | $3,244,000 | -14.0% | 17,100 | +0.6% | 0.00% | -25.0% |
| Q2 2021 | $3,770,000 | +9.3% | 17,000 | +6413.4% | 0.00% | -33.3% |
| Q1 2021 | $3,449,000 | -74.3% | 261 | -66.3% | 0.01% | -64.7% |
| Q4 2020 | $13,410,000 | +47.5% | 775 | -5.1% | 0.02% | +41.7% |
| Q3 2020 | $9,094,000 | +139.6% | 817 | +27.7% | 0.01% | +100.0% |
| Q2 2020 | $3,795,000 | -39.7% | 640 | -31.6% | 0.01% | -45.5% |
| Q1 2020 | $6,296,000 | +73.8% | 935 | +117.4% | 0.01% | +37.5% |
| Q4 2019 | $3,623,000 | +57.9% | 430 | +40.1% | 0.01% | +14.3% |
| Q3 2019 | $2,295,000 | -6.4% | 307 | -20.9% | 0.01% | 0.0% |
| Q2 2019 | $2,453,000 | +42.7% | 388 | +8.7% | 0.01% | +40.0% |
| Q1 2019 | $1,719,000 | +435.5% | 357 | +271.9% | 0.01% | +400.0% |
| Q4 2018 | $321,000 | -72.3% | 96 | -56.6% | 0.00% | -75.0% |
| Q3 2018 | $1,158,000 | +1024.3% | 221 | +569.7% | 0.00% | – |
| Q2 2018 | $103,000 | +66.1% | 33 | -97.1% | 0.00% | -100.0% |
| Q1 2018 | $62,000 | +31.9% | 1,131 | +377.2% | 0.00% | +50.0% |
| Q4 2017 | $47,000 | -11.3% | 237 | +132.4% | 0.00% | 0.0% |
| Q3 2017 | $53,000 | +657.1% | 102 | +137.2% | 0.00% | – |
| Q2 2017 | $7,000 | -50.0% | 43 | -76.0% | 0.00% | -100.0% |
| Q1 2017 | $14,000 | +366.7% | 179 | -29.0% | 0.00% | – |
| Q4 2016 | $3,000 | -92.1% | 252 | -43.1% | 0.00% | -100.0% |
| Q3 2016 | $38,000 | +375.0% | 443 | +195.3% | 0.00% | +200.0% |
| Q2 2016 | $8,000 | -38.5% | 150 | +111.3% | 0.00% | 0.0% |
| Q1 2016 | $13,000 | +18.2% | 71 | -47.4% | 0.00% | 0.0% |
| Q4 2015 | $11,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 670,000 | $22,432,000 | 9.15% |
| SUMMIT SECURITIES GROUP LLC | 100 | $335,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 20,300 | $680,000 | 0.01% |
| SIMPLEX TRADING, LLC | 96 | $321,000 | 0.00% |
| JPMORGAN CHASE & CO | 163,000 | $5,457,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |